Network origin in Richard M. Lawn first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases
52
| Extinct | Biotechnology | 52 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Richard M. Lawn via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree Undergraduate Degree | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Treasurer Corporate Officer/Principal Founder General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
| AFFYMAX, INC. | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal Comptroller/Controller/Auditor | |
Amygdala Neurosciences, Inc.
 Amygdala Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Amygdala Neurosciences, Inc. is a biopharmaceutical company. The firm focuses on improving public health by developing and commercializing therapy to treat substance use disorders. Its development programs include treatment and prevention of opioid, nicotine, alcohol and cocaine use disorders. The company was founded by Lou Lange, Ivan Diamond, Peter Strumph, Brent Blackburn, and Adrienne MacMillan in 2015 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Founder Founder Founder | |
| CYMABAY THERAPEUTICS, INC. | Biotechnology | Human Resources Officer Chairman Corporate Officer/Principal | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| CAPRICOR THERAPEUTICS, INC. | Pharmaceuticals: Major | President Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| ANTHERA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| ALZA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
| New York University | College/University | Undergraduate Degree Undergraduate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal Doctorate Degree | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
The North Carolina Biotechnology Center
 The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services The North Carolina Biotechnology Center provides research and education grants. Its services include financing, technology assessment, business planning, and marketing strategies implementation. The company was founded in 1984 and is headquartered in Research Triangle Park, NC. | Internet Software/Services | Chairman Director/Board Member | |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Rochester Christian University | College/University | Director/Board Member Director/Board Member | |
| Washington University in St. Louis | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| LIMINAL BIOSCIENCES INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
| ESPERION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Compliance Officer | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
InCarda Therapeutics, Inc.
 InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Recardia Therapeutics, Inc. | Director/Board Member President | ||
The University of Liverpool
 The University of Liverpool Other Consumer ServicesConsumer Services The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom. | College/University | Doctorate Degree Doctorate Degree | |
| CYCLACEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| RELYPSA INC | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
| Harvard Law School | College/University | Graduate Degree Graduate Degree | |
| BIOCRYST PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Public Communications Contact | |
| PROTHENA CORPORATION PLC | Biotechnology | General Counsel Comptroller/Controller/Auditor | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of Texas at Austin | College/University | Doctorate Degree Corporate Officer/Principal | |
| CYTOKINETICS, INCORPORATED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| GILEAD SCIENCES, INC. | Biotechnology | Human Resources Officer Corporate Officer/Principal | |
| CODEXIS, INC. | Chemicals: Specialty | Chief Executive Officer Chief Administrative Officer | |
| Rutgers State University of New Jersey | College/University | Doctorate Degree Doctorate Degree | |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Corporate Officer/Principal |
Statistics
International
| United States | 46 |
| United Kingdom | 3 |
| Canada | 2 |
| Ireland | 2 |
| France | 2 |
Sectoral
| Health Technology | 31 |
| Consumer Services | 15 |
| Commercial Services | 3 |
| Health Services | 2 |
| Technology Services | 2 |
Operational
| Director/Board Member | 251 |
| Corporate Officer/Principal | 132 |
| Independent Dir/Board Member | 58 |
| Undergraduate Degree | 40 |
| Chairman | 37 |
Most connected contacts
| Insiders | |
|---|---|
| Peter Hutt | 69 |
| Kenneth Lee | 40 |
| Louis Lange | 35 |
| Santo Costa | 28 |
| Dan Spiegelman | 25 |
| Cam Gallagher | 24 |
| R. Greer | 23 |
| Anders Waas | 21 |
| Thomas Shenk | 21 |
| Peter G. Milner | 18 |
| Joseph M. Davie | 17 |
| Bruce Philip Pritchard | 15 |
| Rebecca Lucia | 12 |
| Kenneth F. Boehm | 12 |
| Barbara McNeil | 11 |
- Stock Market
- Insiders
- Richard M. Lawn
- Company connections
